With the explosion of digitized data and implementation of ACA, pharmaceuticals are being forced to utilize new data and new partners to increase market share for their products. This deck provides an overview of some innovative strategies in commercial data analytics in the BioPharma space.

1. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
September 6th, 2013
Optimal Commercial Data and
Analytics Service Models:
An Overview

2. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Our Expertise
Pharmaceutical Data and Informatics
Nintai Partners’ leadership has nearly a quarter century of experience working with
pharmaceutical data and informatics. Working with everything from traditional IMS sales data,
regulatory CDISC, evidence-based medicine data, and ACO-performance metrics, Nintai
Partners provides the most comprehensive knowledge in the marketplace.
Deep Understanding of Changes in Pharmaceuticals
It isn’t just the breadth and depth of data changing the pharmaceutical world. These data sets
are part of a tremendous change in the industry, ranging from drug discovery/development
outsourcing, a transition from traditional sales to account-based selling models, and the
increasing role of specialty drugs in pharmaceutical companies. portfolios.
Putting It All Together
Nintai Partners presents a truly innovative approach to creating executable solutions. No
engagement is the same and we pride ourselves on unique, partner-driven solutions. We are not
afraid to discuss finding and best practices from outside the industry, as well as providing
unvarnished recommendations to our partners.

3. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Data Services Solution: Core Strategic Drivers
No industry has survived by continually cutting their way to
survival. The ultimate long term health of the industry will
be driven by sustainable and profitable growth. To achieve
this, continued increases in productivity need to occur with
R&D in order to drive the IRR.
New relationships will need to be
created – with incentives for both cost
savings and corporate growth. These
relationships will require more flexible
and integrated business models.
The industry has never been a
leader in the use of informatics,
technology, and integrated data
platforms. The increasing
digitization of data at all levels
(EDC, EMRs, eCTD) is going to
fundamentally change the way we
make decisions.

4. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Data Services Solution: Nintai Partners’ Evaluation Process
Strategic
Need
Step 1
What is the strategic need of
the data infrastructure?
Data
Sources
Step 2
What currently makes up data
source inventory?
Data
Ownership
Step 3
Who currently owns/sponsors
each data asset?
Data Update/
Validation
Step 4
How are these data sources
updated and validated?
Data Access/
Rights
Step 5
Who has access to data and
at what authority ?
Data Regulatory
Needs
Step 6
What regulatory requirements
are required for data?
Nintai Partners utilizes a proprietary six (6) step process to help assess our partners in their
data governance structure. This process assures key constituents that the business processes
and current assets are maximized.

5. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Data Services Solution: Nintai Partners Methodology
As an example of Nintai Partners’ proprietary process, illustrated below is an example of how we
might approach Phase I (Strategic Need).
Data Governance
Board
Sales Sales Ops Marketing IT/IS Finance Regulatory Clinical
Corporate
Strategy &
Key
Objectives
What do we want to
achieve from a new
data informatics
strategy and
organization?
Business
Questions
Answered
What questions need
to be answered by the
proposed strategy,
governance, &
structure?
Proposed
Governance
& Data
Model
What is the best
structure and model
to answer required
questions and meet
key objectives?
Business
Improvement
What changes in
business processes
can drive greater
results and improve
outcomes?
Performance
Review
& Actions
What tools can be
utilized to measure
performance versus
goals and create
executable change?

6. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Data Services Solution: Example of New Data Requirements
Key Tools in ACO Performance Measurement
Specialty
Pharmacy
Data
Emphasis on Lx Data
Patient Adherence
Pharmacy
Performance
Operations
Performance
Clinical Metrics
Economic Measures
Evidence
Based Medicine
Emphasis on EBM
Collaborative
Research
Doctor
Dashboards
Doctor Impact
Labeling
Research
Meta Analysis
Guideline
Consortiums
New Data Sets/Tools
Prescription
Data
Emphasis on Rx Data
Pharma Market
Benchmarking
Forecasting
Pricing &
Market Access
Sales Force
Performance
Existing Data Sets/Tools
Sales
Data
Emphasis on Sales Data
Hospital Dispensed
Non-Reimbursed
OTC (As Applicable)
Price Deviation
VAT Status

7. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Data Services Solution: Case Studies of Nintai Partners’ Work
Case 1: Strategic Shift to Specialty Pharmacy (SP) Portfolio
Working with a team from McKinsey, Nintai Partners developed a targeted data governance
structure which met with key findings. For example, the ability to create a fully integrated
message to specialty physicians about efficacy was roughly 6 times more powerful than
promoting a new MoA. This meant data MUST be fully integrated internally through a
stringent data governance process and included several outside data sources to demonstrate
EBM performance.
Enterprise Data
Warehouse
Internal
Data
Physician prescription data
Anonymous patient-level data
Payer data
CDSC
ETMS
Pre-Clinical (e.g. Dosing Safety)
Phase IV Data
External
Data
Research Meta Analysis
Patient Adherence
Pharmacy Performance
Clinical Metrics
EHR Blinded Data
Guideline Measures
CMS Guidelines
Targeted
Specialist
Campaigns
ACO
Performance
Payer
Formulary
Reimbursement

8. CONFIDENTIAL
Copyright 2014 Nintai Partners
All Rights Reserved. Permission Required Before Duplication.
Case 2: Developing Model Data Governance Model for TBG Integration
Early last year, a partner asked Nintai Partners to evaluate the best data governance model to
integrate a traditionally independent therapeutic business group (TBG) structure. Utilizing an
integrated, multi-department approach Nintai Partners created working groups under a Data
Governance Board to review and come up with dynamic solutions addressing specific
concerns.
Data Services Solution: Case Studies of Nintai Partners Work
Political/
Regulatory
Impacts
Reporting/
Insights
Impact
Business
Process
Impact
Financial
Impact
Vendor
Impacts
Identification of Key Questions, Issues, and Responsibilities
Identification of Working Group Solutions
Roll Up Report to Data Governance Board and TBGs for Feedback